| 标题 |
Postmarketing safety of [ 177 Lu]Lu-PSMA-617 radioligand therapy for prostate cancer: a disproportionality analysis of the FDA adverse event reporting system |
| 网址 | |
| DOI | |
| 其它 |
期刊:Expert Opinion on Drug Safety 作者:Yan Zhao; Na Wang; Zhaoqi Zhang; Xinming Zhao 出版日期:2025-02-12 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)